CoChat

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index; 17 of the 55 sources its claims cite were checked for support.

Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium

Open access
Nie, Jichan, Yi, Yunhua, Liu, Xishi, Guo, Sun-Wei · 2025 · Human Reproduction Open

Abstract

STUDY QUESTION: Do all ectopic endometrial lesions (endometriosis and adenomyosis) universally have activated estrogen signaling? SUMMARY ANSWER: Estrogen signaling diminishes concordantly with increased fibrosis in ectopic endometrium, with deep endometriotic (DE) lesions exhibiting an estrogen biosynthesis capability and estrogen receptor β (ERβ) expression level comparable to that of control endometrium but having suppressed ERα. WHAT IS KNOWN ALREADY: Endometriosis and adenomyosis are both estrogen-dependent diseases driven by estrogen-mediated lesional development, progression, and symptom manifestation. Of note, ectopic endometrium is thought to have the ability to synthesize estradiol (E2) in situ from cholesterol due to upregulation of aromatase (CYP19A1), steroidogenic acute regulatory protein (StAR), 3β-hydroxysteroid dehydrogenase type 2 (HSD3β2), and HSD17β1. In addition to increased estrogen biosynthesis, ERβ and G-protein coupled ER (GPER) are also overexpressed in ectopic endometrium. In particular, the prevailing view holds that prostaglandin E2 plays a vital role in facilitating estrogen biosynthesis and the upregulation of ERβ, positioning itself in the central nexus in a feed-forward loop linking hyperestrogenism and inflammation in all ectopic endometria. STUDY DESIGN, SIZE, DURATION: After obtaining written informed consent, we collected lesional tissues from 19 patients with ovarian endometriosis (OE) and 20 patients each with adenomyosis (AD) and DE. As controls, normal endometrial tissue samples (CT) were procured from 20 cycling women free of endometriosis and adenomyosis, and age- and menstrual phase-matched with patients in the other groups. Additionally, primary ectopic or control endometrial stromal cells derived from eight subjects in each of the OE, AD, DE, and CT groups were cultured for experiments. PARTICIPANTS/MATERIALS, SETTING, METHODS: We performed immunohistochemistry and western blotting to assess the expression of proteins key to the estrogen biosynthesis (StAR, HSD3β2, aromatase, and HSD17β1) and estrogen receptors (ERα, ERβ, and GPER). Fibrosis was quantified via Masson trichrome staining. Real-time RT-PCR was performed to assess corresponding gene expression levels. The estrogen concentrations in cell cultures of primary stromal cells derived from different tissues were also measured by ELISA. MAIN RESULTS AND THE ROLE OF CHANCE: Among all ectopic endometrial tissue samples, the extent of lesional fibrosis was the highest in the DE lesions, followed by the AD and then the OE lesions. The protein and gene expression levels of StAR, HSD3β2, aromatase, and HSD17β1, the four proteins critically involved in estrogen biosynthesis, were significantly higher than in the CT group in OE and AD lesions, but were lowest in DE lesions, which were comparable to that of control endometrium. There was a significantly negative correlation between the expression of these proteins and the extent of lesional fibrosis. Consistently, while the concentration of estrogen in culture supernatants from OE cells was significantly higher than those in CT, it was significantly reduced in AD and DE lesions. In fact, the estrogen concentration in DE cell supernatants was comparable with that in the CT group. The expression of ERβ and GPER was significantly higher in OE and AD lesions than in the CT group and progressively declined with increasing lesional fibrosis; in the DE group, their expression was comparable to the CT group. A significant negative correlation was observed between their expression and the extent of lesional fibrosis. No significant difference in ERα expression was found among different types of ectopic endometrium, but all showed significantly and uniformly lower expression than that of the CT endometrium. LIMITATIONS, REASONS FOR CAUTION: While diminished estrogen signaling concordant with increased lesional fibrosis was demonstrated, no mechanistic data were provided. In addition, while in this study several genes/proteins known to be key to estrogen signaling were evaluated, some other genes/proteins that are also involved in estrogen signaling, such as other members of the HSD17B family, were not evaluated. WIDER IMPLICATIONS OF THE FINDINGS: Our findings challenge the prevailing notion of activated in situ estrogen signaling in ectopic endometrium of all kinds via the feed-forward loop. As such, there is a need to re-appraise our treatment strategies, especially for lesions that are highly fibrotic and thus well advanced. In addition, our findings can be capitalized to help choose the best treatment modality and to inspire novel therapeutics for endometriosis and adenomyosis. STUDY FUNDING/COMPETING INTEREST(S): This research was supported in part by grant 82071623 (S.-W.G.) from the National Natural Science Foundation of China and by grant 202440057 (J.N.) from the Clinical Research Project of Shanghai Municipal Health Commission. S.-W.G. is a member of the Scientific Advisory Board of Heranova, BioSciences and of FimmCyte A.G., and has provided consultancy advice to these companies, as well as to Shanghai Huilun Biotechnology, but these activities had no bearing on this work. The other authors have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

Overview

CoChat Summary

TL;DR

Estrogen signaling in ectopic endometrium diminishes as lesional fibrosis increases, with ovarian endometriosis (OE) and adenomyosis (AD) showing activated estrogen biosynthesis and receptor expression, while deep endometriosis (DE) resembles control endometrium. The findings challenge the view that all ectopic endometrium has universally activated in situ estrogen signaling via the PGE2–estrogen feed-forward loop.

Key findings

  • Lesional fibrosis was highest in DE, followed by AD and then OE; within ectopic endometrium, fibrosis correlated positively with dysmenorrhea severity (Spearman’s r = 0.42, P = 0.0008).
  • StAR, HSD3β2, aromatase, and HSD17β1 were significantly higher in OE and AD than control endometrium (IHC all P ≤ 0.023; RT-PCR all P ≤ 0.023; western blot all P ≤ 0.007), but DE levels were comparable to controls (IHC all P ≥ 0.091; RT-PCR all P ≥ 0.083; western blot all P ≥ 0.065).
  • 17β-estradiol concentrations were 2.69-fold higher in OE and 1.76-fold higher in AD versus controls (P = 0.00017 and P = 0.0011), while DE was comparable to controls (P = 0.33). ERβ and GPER were higher in OE and AD but comparable in DE; ERα was uniformly lower in all ectopic endometrium than controls (IHC all P ≤ 0.014; RT-PCR P ≤ 0.021; western blot P ≤ 0.010).
  • Except for stromal ERα (r = 0.11, P = 0.39), immunostaining levels of the other proteins were negatively correlated with fibrosis extent (all r ≤ −0.39, P ≤ 0.0022); collagen I protein was negatively correlated with 17β-estradiol concentration (r = −0.69, P = 0.00019).

Methods

  • Tissue samples from 19 patients with OE, 20 with AD, 20 with DE, and 20 controls matched by age and menstrual phase; primary stromal cells from 8 subjects per group were cultured. Controls were premenopausal women undergoing hysterectomy for high-grade squamous intraepithelial lesions of the cervix, free of other benign or malignant gynecological diseases, and no hormonal medication for at least 3 months.
  • Immunohistochemistry, Masson trichrome staining, real-time RT-PCR, western blotting, and ELISA were used to assess estrogen biosynthesis enzymes (StAR, HSD3β2, aromatase, HSD17β1), estrogen receptors (ERα, ERβ, GPER), fibrosis, and 17β-estradiol concentrations.
  • Statistical analysis used Wilcoxon’s rank test, Pearson’s or Spearman’s correlation, and multiple linear regression incorporating age, menstrual phase, parity, and co-occurrence of OE, AD, DE, and uterine fibroids; analyses were performed in R version 4.4.2.

Limitations

  • Stated: no mechanistic data were provided linking fibrosis and diminished estrogen signaling; several other estrogen-signaling genes/proteins, such as other HSD17B family members, were not evaluated.
  • Stated: only diffuse AD samples were used, which may limit generalizability; sample size for each ectopic endometrium subtype was moderate, though collectively reasonably large.
  • Evident from the text: the design is cross-sectional and observational, so causality cannot be established; controls were women undergoing hysterectomy for HSIL rather than healthy community controls, which may affect comparability of control endometrium.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/hropen/hoaf028

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Relationship between lesional fibrosis and dysmenorrhea severity, and protein expression levels of collagen I. Boxplot showing the relationship between the extent of lesional fibrosis and the VAS scores on dysmenorrhea (A). In (B), the protein expression levels of collagen I in the four different groups are presented. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis; VAS, visual analog scale. Symbols for statistical significance levels: **P < 0.01; ***P < 0.001.
Figure 1. Relationship between lesional fibrosis and dysmenorrhea severity, and protein expression levels of collagen I. Boxplot showing the relationship between the extent of lesional fibrosis and the VAS scores on dysmenorrhea (A). In (B), the protein expression levels of collagen I in the four different groups are presented. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis; VAS, visual analog scale. Symbols for statistical significance levels: **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Figure 2. Results of immunohistochemistry analysis of proteins involved in the estrogen signaling pathway. The representative photomicrographs (left panel) of the immunostaining of StAR, HSD3β2, aromatase, HSD17β1, and estrogen receptors ERα, ERβ, and G-protein coupled ER (GPER) in normal endometrium (CT), ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples, along with data summary (right panel). Sample sizes: CT: n = 20; OE: n = 19; AD: n = 20; DE: n = 20. Magnification: × 400. Scale bar= 50 μm. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, *: compared with the CT group).
Figure 2. Results of immunohistochemistry analysis of proteins involved in the estrogen signaling pathway. The representative photomicrographs (left panel) of the immunostaining of StAR, HSD3β2, aromatase, HSD17β1, and estrogen receptors ERα, ERβ, and G-protein coupled ER (GPER) in normal endometrium (CT), ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples, along with data summary (right panel). Sample sizes: CT: n = 20; OE: n = 19; AD: n = 20; DE: n = 20. Magnification: × 400. Scale bar= 50 μm. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, *: compared with the CT group).CC BY · PubMed Central
Figure 3. Correlation between the extent of lesional fibrosis and epithelial staining levels of markers of estrogen signaling. Scatter plots showing the relationship between the extent of lesional fibrosis and the staining levels of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERα (E), ERβ (F), and G-protein coupled ER (GPER) (G) in ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples. In all plots, the dashed line represents the linear regression line, and Pearson’s correlation coefficient, along with its statistical significance level, is shown. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3. Correlation between the extent of lesional fibrosis and epithelial staining levels of markers of estrogen signaling. Scatter plots showing the relationship between the extent of lesional fibrosis and the staining levels of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERα (E), ERβ (F), and G-protein coupled ER (GPER) (G) in ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples. In all plots, the dashed line represents the linear regression line, and Pearson’s correlation coefficient, along with its statistical significance level, is shown. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Figure 4. Correlation between the extent of lesional fibrosis and stromal staining levels of markers of estrogen signaling. Scatter plots showing the relationship between the extent of lesional fibrosis and the staining levels of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERβ (E), and G-protein coupled ER (GPER) (F) in ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples. In all plots, the dashed line represents the linear regression line, and Pearson’s correlation coefficient, along with its statistical significance level, is shown. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 4. Correlation between the extent of lesional fibrosis and stromal staining levels of markers of estrogen signaling. Scatter plots showing the relationship between the extent of lesional fibrosis and the staining levels of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERβ (E), and G-protein coupled ER (GPER) (F) in ovarian endometrioma (OE), adenomyosis (AD), and deep endometriosis (DE) tissue samples. In all plots, the dashed line represents the linear regression line, and Pearson’s correlation coefficient, along with its statistical significance level, is shown. Symbols for statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Figure 5. Results of gene expression analysis. Relative fold change in gene expression of STAR, HSD3B2, CYP19A1, HSD17B1, ESR1, ESR2, and G-protein coupled ER (GPER) (A–G). GAPDH expression levels served as a loading control. All data were expressed as fold change in protein expression relative to the CT group. Symbols of statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, compared with the CT group). Data are represented in means±SDs. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis.
Figure 5. Results of gene expression analysis. Relative fold change in gene expression of STAR, HSD3B2, CYP19A1, HSD17B1, ESR1, ESR2, and G-protein coupled ER (GPER) (A–G). GAPDH expression levels served as a loading control. All data were expressed as fold change in protein expression relative to the CT group. Symbols of statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, compared with the CT group). Data are represented in means±SDs. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis.CC BY · PubMed Central
Figure 6. Results of protein expression analysis and ELISA results. Relative fold change in protein expression of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERα (E), ERβ (F), and G-protein coupled ER (GPER) (G). The GAPDH expression levels were served as a loading control. All data were expressed as fold change in protein expression relative to the CT group. (H) Estradiol concentrations measured by ELISA in supernatant of cultured cells derived from different tissues. Symbols of statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, compared with the CT group). Data are represented in means±SDs. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis.
Figure 6. Results of protein expression analysis and ELISA results. Relative fold change in protein expression of StAR (A), HSD3β2 (B), aromatase (C), HSD17β1 (D), ERα (E), ERβ (F), and G-protein coupled ER (GPER) (G). The GAPDH expression levels were served as a loading control. All data were expressed as fold change in protein expression relative to the CT group. (H) Estradiol concentrations measured by ELISA in supernatant of cultured cells derived from different tissues. Symbols of statistical significance levels: NS: P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (by Wilcoxon’s rank test, compared with the CT group). Data are represented in means±SDs. CT, control endometrium; OE, ovarian endometriomas; AD, adenomyosis; DE, deep endometriosis.CC BY · PubMed Central

Verification

Claims the paper makes

14 Valid · 1 Not valid · 21 Not checked · 92 Own results and interpretations

59 more claims · 1 with their cited sources checked

Create a free account to see all 128 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 44
  • Probably not a substantial claim. 28

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 86 references

Cited by

See all 11

Metadata

Authors
Nie, J., Yi, Y., Liu, X., & Guo, S.-W.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Fudan University (CN)
Corresponding author
Guo, Sun-Wei
Venue
Human Reproduction Open
Published
2025
Volume
2025
Issue
3
Pages
hoaf028-hoaf028
ISSN
2399-3529 (ISSN-L)
OpenAlex
W4410398443
Cited by
11
References
86
Citations by year
2026: 7 · 2025: 4
FWCI
9.65
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (202440057)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
endometriosis, adenomyosis, deep infiltrating endometriosis, estrogen signaling, fibrosis, estrogen synthesis, estrogen receptor beta, estrogen receptor alpha, G protein-coupled estrogen receptor, aromatase, steroidogenic acute regulatory protein, endometrial stromal cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium. https://app.cochat.ai/papers/10.1093/hropen/hoaf028
The paper
Nie, J., Yi, Y., Liu, X., & Guo, S.-W. (2025). Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium. Human Reproduction Open. https://doi.org/10.1093/hropen/hoaf028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.